Literature DB >> 8091123

Salivary flow rate, buffering capacity, and yeast counts in 187 consecutive adult patients from Kuopio, Finland.

J H Meurman1, P Rantonen.   

Abstract

The aim of this study was to investigate salivary flow rate, buffering capacity, and yeast counts in all adult patients seeking dental treatment at the University Dental Clinic in Kuopio, Finland, during autumn 1992. Altogether, 187 consecutive patients over 20 yr old were included. Stimulated and unstimulated salivary flow rates were as follows: 1.8 +/- 0.9 ml/min; 0.6 +/- 0.4 ml/min in men, and 1.3 +/- 0.7 ml/min; 0.4 +/- 0.3 ml/min in women. A total of 103 patients used one or more systemic medications daily, mainly for cardiovascular disease (29.9%). The patients with medication had significantly lower flow rates than unmedicated subjects; in particular, in the older age group over 60 yr old. The medicated subjects also had significantly more often low buffering capacity values than the unmedicated ones (20% and 7%, respectively, with pH < 4 in the Dentobuff score). Positive yeast counts were observed in 66% of men and 55% of women, and more often in medicated than in unmedicated subjects (63% and 57%, respectively, NS). The results emphasize the need to take patients' sex and systemic medication into account in all salivary diagnoses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8091123     DOI: 10.1111/j.1600-0722.1994.tb01185.x

Source DB:  PubMed          Journal:  Scand J Dent Res        ISSN: 0029-845X


  10 in total

1.  Salivary constituents and acidogenic microbial counts in coronary artery bypass graft patients from baseline to three-years after operation.

Authors:  Markku Qvarnström; Sok-Ja Janket; Pekka Nuutinen; Jussi Furuholm; Jukka H Meurman
Journal:  Clin Oral Investig       Date:  2007-03-31       Impact factor: 3.573

2.  Saliva in perimenopausal and early postmenopausal women. A 2-year follow-up study.

Authors:  Laura Tarkkila; Jussi Furuholm; Aila Tiitinen; Jukka H Meurman
Journal:  Clin Oral Investig       Date:  2011-06-03       Impact factor: 3.573

3.  Comparison of three strip-type tests and two laboratory methods for salivary buffering analysis.

Authors:  Zeinab Cheaib; Carolina Ganss; Andreas Lamanda; Melek Dilek Turgut; Adrian Lussi
Journal:  Odontology       Date:  2011-05-10       Impact factor: 2.634

4.  Evaluation of nasal mucociliary activity in patients with chronic renal failure.

Authors:  Cuneyt Kucur; Isa Ozbay; Erim Gulcan; Semra Kulekci; Sinan Aksoy; Fatih Oghan
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-11       Impact factor: 2.503

5.  Evaluation of Salivary Components and Dental Plaque in Relation to Dental Caries Status in Type 1 Diabetes Mellitus.

Authors:  R Manjushree; Latha Anandakrishna; Keerthi Prasad Ks; Ashmitha K Shetty
Journal:  Int J Clin Pediatr Dent       Date:  2022

6.  Oral health in predialysis patients with emphasis on diabetic nephropathy.

Authors:  Maarit Vesterinen; Hellevi Ruokonen; Jussi Furuholm; Eero Honkanen; Jukka H Meurman
Journal:  Clin Oral Investig       Date:  2010-01-19       Impact factor: 3.573

7.  Oral health in perimenopausal and early postmenopausal women from baseline to 2 years of follow-up with reference to hormone replacement therapy.

Authors:  L Tarkkila; J Furuholm; A Tiitinen; J H Meurman
Journal:  Clin Oral Investig       Date:  2008-02-26       Impact factor: 3.573

Review 8.  Salivary biomarkers for caries risk assessment.

Authors:  Lihong Guo; Wenyuan Shi
Journal:  J Calif Dent Assoc       Date:  2013-02

9.  Physics of chewing in terrestrial mammals.

Authors:  Emmanuel Virot; Grace Ma; Christophe Clanet; Sunghwan Jung
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

10.  Risk factors associated with oral manifestations and oral health impact of gastro-oesophageal reflux disease: a multicentre, cross-sectional study in Pakistan.

Authors:  Ibrahim Warsi; Javeria Ahmed; Anjum Younus; Abdur Rasheed; Tayyab Saeed Akhtar; Qurrat Ul Ain; Zohaib Khurshid
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.